Recognition of the earliest signs and symptoms of chronic graft-versus-host disease (GVHD)
that lead to severe manifestations remains a challenge. The standardization provided by the …

Graft-versus-host disease (GVHD) is the most important complication of allogeneic
hematopoietic stem cell transplantation (alloHSCT). We performed a prospective …

Importance Chronic graft-vs-host disease (GVHD) limits the long-term benefit of
haploidentical hematopoietic stem cell transplant (HSCT). This clinical trial evaluated …

Importance Chronic graft-vs-host disease (GVHD) is associated with impaired quality of life
and symptom burden. The independent association of skin involvement with patient …

Background HLA compatibility predicts allogeneic hematopoietic cell transplant (allo-HCT)
and graft-versus-host disease (GvHD) outcomes. There is insufficient information regarding …

Background Patients are affected by various symptoms after allogeneic hematopoietic stem
cell transplantation (allo-HSCT) that can affect recovery. Research has mainly focused on …

Simple Summary Patients who have been treated with an allogeneic, hematopoietic stem
cell transplantation can develop severe graft-versus-host disease. This complication may …

Background Pediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors
(TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor-if available …

Background Chronic graft-versus-host disease (cGVHD) is the most serious non-relapse
complication affecting long-term allogeneic hematopoietic cell transplantation (HCT) …

Importance Cutaneous chronic graft-vs-host disease (GVHD) is independently associated
with morbidity and mortality after allogeneic hematopoietic cell transplant. However, the …